SPOTLIGHT -
Commercial Sustainability of Pharmaceutical Innovations for Pandemics
Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.
Measuring the Probability of Pricing and Access Success
There is still no structured method of assessing pricing and access risk for drug manufacturers. Presented here is a straightforward measure for integrating pricing and access risk into portfolio planning and decision-making.